Jazz Pharmaceuticals
JAZZ
#1524
Rank
โ‚ฌ12.33 B
Marketcap
196,53ย โ‚ฌ
Share price
-0.55%
Change (1 day)
113.55%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): -โ‚ฌ0.19 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ4.43 Billion. In 2025 the company made an earning of -โ‚ฌ0.54 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.19 Billion-66.23%
2025 -โ‚ฌ0.54 Billion-233.48%
2024 โ‚ฌ0.40 B57.87%
2023 โ‚ฌ0.25 B-179.92%
2022 -โ‚ฌ0.32 Billion230.37%
2021 -โ‚ฌ95.99 Million-141.02%
2020 โ‚ฌ0.23 B-39.45%
2019 โ‚ฌ0.38 B-14.2%
2018 โ‚ฌ0.45 B20.03%
2017 โ‚ฌ0.37 B-17.15%
2016 โ‚ฌ0.45 B22.14%
2015 โ‚ฌ0.37 B187.64%
2014 โ‚ฌ0.12 B-50.79%
2013 โ‚ฌ0.26 B73.63%
2012 โ‚ฌ0.15 B41.69%
2011 โ‚ฌ0.10 B116.61%
2010 โ‚ฌ49.15 M262.77%
2009 โ‚ฌ13.55 M-111.33%
2008 -โ‚ฌ0.12 Billion1.31%
2007 -โ‚ฌ0.12 Billion77.8%
2006 -โ‚ฌ66.4 Million36.59%
2005 -โ‚ฌ48.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.42 B-7,312.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
โ‚ฌ1.78 B-1,058.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚ฌ2.04 Billion 992.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.93 B-1,137.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel